BioCentury
ARTICLE | Company News

Abbott to acquire Vysis

October 24, 2001 7:00 AM UTC

ABT will acquire diagnostics company VYSI for $30.50 per share, valuing the deal at $335 million. ABT will make a cash tender offer for VYSI shares, and anticipates closing the deal by year end. Amoco Technology, which owns 65% of VYSI, will tender its VYSI shares as part of ABT's tender offer. ...